-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KzoLu2zn4a7r7LjOlFuKGmHan6eULrCbavDmWuJdeeYFxh2q+ld1Ym5+9Gd4dMTM iOaNZFAdKLz91gRM7lHPNA== 0000950120-99-000156.txt : 19990514 0000950120-99-000156.hdr.sgml : 19990514 ACCESSION NUMBER: 0000950120-99-000156 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 19990513 GROUP MEMBERS: GALEN ASSOCIATES GROUP MEMBERS: GALEN PARTNERS INTERNATIONAL, L.P. GROUP MEMBERS: GALEN PARTNERS L P GROUP MEMBERS: WILLIAM R. GRANT SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OCULAR SCIENCES INC /DE/ CENTRAL INDEX KEY: 0000882484 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 942985696 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-52699 FILM NUMBER: 99620083 BUSINESS ADDRESS: STREET 1: 475 ECCLES AVE CITY: S SAN FRANCISCO STATE: CA ZIP: 94080 MAIL ADDRESS: STREET 1: 475 ECCLES AVE CITY: S SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: O S I CORP DATE OF NAME CHANGE: 19970506 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GALEN PARTNERS L P CENTRAL INDEX KEY: 0000841156 STANDARD INDUSTRIAL CLASSIFICATION: [] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 BUSINESS PHONE: 2122184990 MAIL ADDRESS: STREET 1: 610 FIFTH AVE STREET 2: 5TH FL CITY: NEW YORK STATE: NY ZIP: 10020 SC 13G/A 1 AMENDMENT NO. 1 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* OCULAR SCIENCES, INC. ----------------------------------------------------------------- (Name of Issuer) COMMON STOCK ----------------------------------------------------------------- (Title of Class of Securities) 675744 10 6 ----------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [ ]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 14 pages SCHEDULE 13G ----------------------- ------------------------- CUSIP No. 675744 10 6 Page 2 of 14 Pages ------------- ----- ----- ----------------------- ------------------------- ----------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON GALEN PARTNERS, L. P. ----------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] ----------------------------------------------------------------- 3 SEC USE ONLY ----------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE ----------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ----------------------------------------------------------------- 5 SOLE VOTING POWER 682,564 ----------------------------------------------------------------- 6 SHARED VOTING POWER - 0 - ----------------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 682,564 ----------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER - 0 - ----------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 682,564 ----------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] Excludes 11,010 shares held of record by Galen Associates and 20,016 shares subject to options that are currently exercisable by William R. Grant. ----------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.02% ----------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN ----------------------------------------------------------------- SCHEDULE 13G ----------------------- ------------------------- CUSIP No. 675744 10 6 Page 3 of 14 Pages ------------- ----- ----- ----------------------- ------------------------- ----------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON GALEN PARTNERS INTERNATIONAL, L.P. ----------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [X] (b) [ ] ----------------------------------------------------------------- 3 SEC USE ONLY ----------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ----------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ----------------------------------------------------------------- 5 SOLE VOTING POWER 70,299 ----------------------------------------------------------------- 6 SHARED VOTING POWER - 0 - ----------------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 70,299 ----------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER - 0 - ----------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 70,299 ----------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] Excludes 11,010 shares held of record by Galen Associates and 20,016 shares subject to options that are currently exercisable by William R. Grant. ----------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.31% ----------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN ----------------------------------------------------------------- SCHEDULE 13G ----------------------- ------------------------- CUSIP No. 675744 10 6 Page 4 of 14 Pages ------------- ----- ----- ----------------------- ------------------------- ----------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON GALEN ASSOCIATES ----------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] ----------------------------------------------------------------- 3 SEC USE ONLY ----------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ----------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ----------------------------------------------------------------- 5 SOLE VOTING POWER 11,010 ----------------------------------------------------------------- 6 SHARED VOTING POWER - 0 - ----------------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 11,010 ----------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER - 0 - ----------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 11,010 ----------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [X] Excludes 20,016 shares subject to options that are currently exercisable by William R. Grant. ----------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) .05% ----------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN ----------------------------------------------------------------- SCHEDULE 13G ---------------------- ------------------------- CUSIP No. 675744 10 6 Page 5 of 14 Pages ------------ ----- ----- ---------------------- ------------------------- ----------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON WILLIAM R. GRANT ----------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] ----------------------------------------------------------------- 3 SEC USE ONLY ----------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. ----------------------------------------------------------------- NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH ----------------------------------------------------------------- 5 SOLE VOTING POWER 62,575 ----------------------------------------------------------------- 6 SHARED VOTING POWER - 0 - ----------------------------------------------------------------- 7 SOLE DISPOSITIVE POWER 82,591, including 20,016 shares subject to options that are currently exercisable. ----------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER - 0 - ----------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 82,591, including 20,016 shares subject to options that are currently exercisable. ----------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] ----------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.36% ----------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN ----------------------------------------------------------------- The initial Schedule 13G, dated February 12, 1998, is hereby amended, on behalf of each Reporting Person, to reflect (i) the sale by the Reporting Persons, Galen Partners, L.P. and Galen Partners International, L.P., of an aggregate of 1,001,196 shares of Common Stock, as of March 24, 1998, pursuant to an underwritten public offering, (ii) the pro rata distribution by the Reporting Persons, Galen Partners, L.P and Galen Partners International, L.P., to their respective partners of an aggregate of 700,000 shares of Common Stock, as of April 27, 1999, and (iii) the pro rata distribution by the Reporting Persons, Galen Partners, L.P. and Galen Partners International, L.P., to their respective partners of an aggregate of 500,000 shares of Common Stock, as of May 11, 1999. Set forth below, as identified by Reporting Person, is an amended Item 4 showing the ownership of shares of Common Stock following such transactions. ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: -------------------------------------------------------- (a) Ocular Sciences, Inc. (b) 475 Eccles Avenue South San Francisco, CA 94080 ITEM 2. INFORMATION CONCERNING PERSON FILING: ------------------------------------ (a) Galen Partners, L.P. (b) 610 Fifth Avenue, 5th Floor Rockefeller Center New York, NY 10020 (c) Delaware (d) Common Stock (e) 675744 10 6 ITEM 4. OWNERSHIP: --------- (a) 682,564 (b) 3.02% (c) (i) Sole power to vote or to direct vote: 682,564 shares (ii) Shared power to vote or to direct vote: 0 shares (iii) Sole power to dispose or to direct the disposition: 682,564 shares (iv) Shared power to dispose or to direct the disposition: 0 shares Page 6 of 14 pages ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: -------------------------------------------------------- (a) Ocular Sciences, Inc. (b) 475 Eccles Avenue South San Francisco, CA 94080 ITEM 2. INFORMATION CONCERNING PERSON FILING: ------------------------------------ (a) Galen Partners International, L.P. (b) 610 Fifth Avenue, 5th Floor Rockefeller Center New York, NY 10020 (c) Delaware (d) Common Stock (e) 675744 10 6 ITEM 4. OWNERSHIP: --------- (a) 70,299 (b) 0.31% (c) (i) Sole power to vote or to direct vote: 70,299 shares (ii) Shared power to vote or to direct vote: 0 shares (iii) Sole power to dispose or to direct the disposition: 70,299 shares (iv) Shared power to dispose or to direct the disposition: 0 shares Page 7 of 14 pages ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: -------------------------------------------------------- (a) Ocular Sciences, Inc. (b) 475 Eccles Avenue South San Francisco, CA 94080 ITEM 2. INFORMATION CONCERNING PERSON FILING: ------------------------------------ (a) Galen Associates (b) 610 Fifth Avenue, 5th Floor Rockefeller Center New York, NY 10020 (c) Delaware (d) Common Stock (e) 675744 10 6 ITEM 4. OWNERSHIP: --------- (a) 11,010 (b) 0.05% (c) (i) Sole power to vote or to direct vote: 11,010 shares (ii) Shared power to vote or to direct vote: 0 shares (iii) Sole power to dispose or to direct the disposition: 11,010 shares (iv) Shared power to dispose or to direct the disposition: 0 shares Page 8 of 14 pages ITEM 1. ISSUER'S NAME AND ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: -------------------------------------------------------- (a) Ocular Sciences, Inc. (b) 475 Eccles Avenue South San Francisco, CA 94080 ITEM 2. INFORMATION CONCERNING PERSON FILING: ------------------------------------ (a) William R. Grant (b) 610 Fifth Avenue, 5th Floor Rockefeller Center New York, NY 10020 (c) U.S.A. (d) Common Stock (e) 675744 10 6 ITEM 4. OWNERSHIP: --------- (a) 62,575 (b) 0.36% (c) (i) Sole power to vote or to direct vote: 62,575 shares (ii) Shared power to vote or to direct vote: 0 shares (iii) Sole power to dispose or to direct the disposition: 82,591 including 20,016 shares subject to options that are currently exercisable (iv) Shared power to dispose or to direct the disposition: 0 shares Page 9 of 14 pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. May 12, 1999 ----------------------------------- Date GALEN PARTNERS, L.P. By: BGW Partners, L.P. General Partner By: /s/ Bruce F. Wesson ------------------------------- Name: Bruce F. Wesson Title: General Partner GALEN PARTNERS INTERNATIONAL, L.P. By: BGW PARTNERS, L.P. General Partner By: /s/ Bruce F. Wesson ------------------------------- Name: Bruce F. Wesson Title: General Partner Page 10 of 14 pages GALEN ASSOCIATES By: WESSON ENTERPRISES, INC. General Partner By: /s/ Bruce F. Wesson ------------------------------- Name: Bruce F. Wesson Title: President /s/ William R. Grant ----------------------------------- William R. Grant Page 11 of 14 pages EXHIBIT INDEX Sequentially Exhibit Document Description Numbered Page ------- -------------------- ------------- A Agreement of Joint Filing 13 Page 12 of 14 pages EX-99 2 EXHIBIT A EXHIBIT A Agreement of Joint Filing Each of the undersigned hereby agrees that they are filing jointly pursuant to Rule 13d-1(f)(1) of the Securities Exchange Act of 1934, as amended, the Statement dated May 10, 1999, containing the information required by Schedule 13G, for the shares of Common Stock of Ocular Sciences, Inc. which are held of record by Galen Partners, L.P., Galen Partners International, L.P., Galen Associates and William R. Grant and beneficially owned by the undersigned. Each of the undersigned hereby expressly disclaims beneficial ownership of any of such shares as to which he or it does not have an actual pecuniary interest. DATED: May 12, 1999 GALEN PARTNERS, L.P. By: BGW PARTNERS, L.P. General Partner By: /s/ Bruce F. Wesson ------------------------- Name: Bruce F. Wesson Title: General Partner GALEN PARTNERS INTERNATIONAL, L.P. By: BGW PARTNERS, L.P. General Partner By: /s/ Bruce F. Wesson ------------------------------- Name: Bruce F. Wesson Title: General Partner Page 13 of 14 pages GALEN ASSOCIATES By: WESSON ENTERPRISES, INC. General Partner By: /s/ Bruce F. Wesson ------------------------------- Name: Bruce F. Wesson Title: President /s/ William R. Grant ----------------------------------- William R. Grant Page 14 of 14 pages -----END PRIVACY-ENHANCED MESSAGE-----